I 
116TH CONGRESS 
2D SESSION 
H. R. 8652 
To amend title XVIII of the Social Security Act to provide coverage and 
payment under such title for certain treatments for dialysis-related amy-
loidosis, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
OCTOBER 23, 2020 
Mr. BABIN introduced the following bill; which was referred to the Committee 
on Energy and Commerce, and in addition to the Committee on Ways 
and Means, for a period to be subsequently determined by the Speaker, 
in each case for consideration of such provisions as fall within the juris-
diction of the committee concerned 
A BILL 
To amend title XVIII of the Social Security Act to provide 
coverage and payment under such title for certain treat-
ments for dialysis-related amyloidosis, and for other pur-
poses. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Dialysis-Related Amy-
loidosis Treatment Act of 2020’’. 
VerDate Sep 11 2014 
18:40 Nov 06, 2020
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H8652.IH
H8652
pamtmann on DSKBC07HB2PROD with BILLS
SEC. 2. COVERAGE AND PAYMENT FOR TREATMENTS FOR 
DIALYSIS-RELATED 
AMYLOIDOSIS 
UNDER 
THE MEDICARE PROGRAM. 
(a) COVERAGE.—Section 1861(s)(2) of the Social Se-
curity Act (42 U.S.C. 1395x(s)(2)), is amended— 
(1) in subparagraph (GG), by striking ‘‘and’’ at 
the end; 
(2) in subparagraph (HH), by striking the pe-
riod at the end and inserting ‘‘; and’’; and 
(3) by adding at the end the following new sub-
paragraph: 
‘‘(II) treatments for dialysis-related amyloidosis 
(as defined in subsection (kkk)).’’. 
(b) TREATMENTS FOR DIALYSIS-RELATED AMYLOI-
DOSIS DEFINED.— 
(1) IN GENERAL.—Section 1861 of the Social 
Security Act (42 U.S.C. 1395x), is amended by add-
ing at the end the following new subsection: 
‘‘(kkk) TREATMENTS FOR DIALYSIS-RELATED AMY-
LOIDOSIS.—The term ‘treatments for dialysis-related amy-
loidosis’ means any item or service that is furnished in 
a dialysis facility (freestanding or hospital-based) that is 
approved by the Food and Drug Administration for the 
treatment of dialysis-related amyloidosis, and any supplies 
or services that are provided adjunct to and are necessary 
for such treatment.’’. 
VerDate Sep 11 2014 
18:40 Nov 06, 2020
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H8652.IH
H8652
pamtmann on DSKBC07HB2PROD with BILLS
(2) EXCLUSION FROM RENAL DIALYSIS SERV-
ICES.—Section 1881(b)(14)(B) of the Social Secu-
rity Act (42 U.S.C. 1395rr(b)(14)(B)) is amended 
by inserting before the period at the end the fol-
lowing: ‘‘or ‘treatments for dialysis-related amyloi-
dosis’ (as defined in section 1861(kkk))’’. 
(c) PAYMENT.—Section 1833(a)(1)(E) of the Social 
Security Act (42 U.S.C. 1395l(a)(1)(E)) is amended by 
inserting at the end the following: ‘‘except for treatments 
for dialysis-related amyloidosis, which may not be included 
as a renal dialysis service for purposes of payment under 
any prospective payment amount or comprehensive fee es-
tablished under section 1881, and for which payment shall 
be made separately in the amount of 100 percent of the 
reasonable charges for such items and services,’’. 
(d) EFFECTIVE DATE.—The amendments made by 
this section shall take effect on the date of the enactment 
of this Act. 
Æ 
VerDate Sep 11 2014 
18:40 Nov 06, 2020
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H8652.IH
H8652
pamtmann on DSKBC07HB2PROD with BILLS